Thanks, that is actually really good to know. I know that all companies running phase 2 and 3 trials must have an EAP, but wasn’t sure if MSB were still actively approving compassionate use given the product is so close to approval. Glad they still are.
MSB Trading - 2020, page-688
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
-0.025(1.98%) |
Mkt cap ! $1.410B | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.30 | $1.23 | $7.194M | 5.674M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 14648 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.24 | 23806 | 23 |
View Market Depth
| Last trade - 13.57pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.23 |
Change
-0.025 ( 3.67 %) |
||||
| Open | High | Low | Volume | ||
| $1.26 | $1.29 | $1.23 | 1086866 | ||
| Last updated 14.12pm 29/05/2024 ? | |||||
| MSB (ASX) Chart |